Summary
Bilateral administration of ergometrine into the nucleus accumbens of rats pretreated 1–3 min earlier with intra-accumbens injections of noradrenaline, phenylephrine, clonidine and phentolamine has been found to produce a normal ergometrine-induced hyperactivity. In contrast, low doses of dopamine and (3,4-dihydroxyphenylimino)-2-imidazoline (DPI) and only high doses of clonidine and phentolamine have been found to attenuate the ergometrine response. These data together with the finding that phentolamine is unable to alter DPI’s ability to suppress the ergometrine response provide direct evidence that the latter DPI effect is certainly not due to its ability to act as an agonist at α-NE receptors within the nucleus accumbens of rats.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bell, C., Conway, E. L., Lan and W. L.: Ergometrine and apomorphine as selective antagonists of dopamine in the canine renal musculature. Pharmac. 52, 591–595 (1974).
Blackburn, K.J., Bremner, R. M., Greengrass, P. M., Morville, M.: Selective affinities of bromocriptine and lergotrile for rat limbic dopamine binding sites. Br. J. Pharmac. 64, 413 P (1978).
Mesolimbic Catecholamine Receptors, DPI and Hyperactivity in Rats 187
Cerletti, A., Doefner, W.: Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and ergot alkaloids. J. Pharmacol. exp. Ther. 122, 124–138 (1958).
Cools, A.R.: Two functionally and pharmacologically distinct dopamine receptors in the rat brain. Adv. Biochem. Pharmacol. 16, 215–225 (1977 a).
Cools, A.R.: Basic considerations of the role of concertedly working dopaminergic, GABA-ergic, cholinergic and serotonergic mechanisms within the neostriatum and nucleus accumbens in locomotor activity, stereotyped gnawing, turning and dyskinetic activities. In: Advances in Behavioural Biology, Vol. 21 (Proceedings of Symposium on Contemporary Issues in Stimulant Research, Durham 1975), pp. 98–142. New York: Plenum Publishing Corporation. 1977 b.
Cools, A.R.: Ergometrine and its biphasic action at dopaminergic receptors in the nucleus accumbens of rats. Pharmacology 16, suppl. 1, 9–14 (1978).
Cools, A.R., Honig, W. M. M., Pijnenburg, A.J.J., Van Rossum, J. M.: The nucleus accumbens of rats and dopaminergic mechanisms regulating locomotor behaviour. Neurosci. Letters 3, 335–339 (1976 a).
Cools, A.R., Struyker Boudier, H. A.J., Van Rossum, J M.: Dopamine receptors: selective agonists and antagonists of functionally distinct types within the feline brain. Europ. J. Pharmacol. 37, 283–293 (1976 b).
Cools, A. R., Van Rossum, J. M.: Multiple receptors for brain dopamine in behavioural regulation: concept of dopamine-e and dopamine-i receptors. Life Sci. 27, 1237–1253 (1980).
Costall, B., Naylor, R.J.: Apomorphine as an antagonist of the dopamine response from the nucleus accumbens. J. Pharm. Pharmacol. 28, 592–595 (1976).
Costall, B., Hui, S.-C. G., Naylor, R.J.: The importance of serotonergic mechanisms for the induction of hyperactivity by amphetamine and its antagonism by intra-accumbens (3,4-dihydroxy-phenylamino)-2imidazole (DPI). Neuropharmacol. 18, 605–609 (1979).
Drummond, A., Bucher, F., Levitan,J.: LSD labels as novel dopamine receptor in molluscan nervous system. Nature 272, 368–370 (1978).
König, F. R.J., Klippel, R. R.: The Rat Brain. Baltimore: Williams and Wilkins. 1963.
Megens, A. A. P. H., Cools, A.R.: Presence of a particular subpopulation of dopamine receptors within the septal nuclei: a behavioural study on cats. Europ. J. Pharmacol. 71, 247–258 (1981).
Pijnenburg, A.J.J., Woodruff, G. N., Van Rossum, J. M.: Ergometrine induced locomotor activity following intracerebral injection into the nucleus accumbens. Brain Res. 59, 289–302 (1973).
Pijnenburg, A.J.J., Honig, W. M. M., Van Rossum, J. M.: Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated rats. Psychopharmacologia (Berl.) 41, 175–180 (1975).
Pijnenburg, A.J.J., Honig, W. M. M., Struyker Boudier, H. A.J., Cools, A. R., Van der Heyden, J.A. M., Van Rossum, J M.: Further investigations on the effects of ergometrine and other ergot derivatives following injection into the nucleus accumbens of rats. Arch. in Pharmacodyn. 222, 103–115 (1976 a).
Pijnenburg, A.J.J., Honig, W. M. M., Van der Heyden, J. A. M., Von Rossum, J. M.: Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Europ. J. Pharmacol. 35, 45–58 (1976 b).
Ruffolo, R. R., jr., Yaden, E. L., Waddell, J. E., Dillard, R. D.: Receptor interactions of imidazolines. VI. Significance of carbon bridge separating phenyl and imidazoline rings of tolazoline-like alpha adrenergic imidazolines. J. Pharmacol. exp. Ther. 214, 535–540 (1980).
Springer, J., Hannigan, J. H., jr., Isaacson, R. L.: Changes in dopamine and DOPAC following systemic administration of apomorphine and 3,4-dihydroxyphenylamino-2-imidazoline (DPI) in rats. Brain Res. 220, 226–230 (1981).
Struyker Boudier, H., Gielen, W., Cools, A.R., Van Rossum, J M.: Pharmacological analysis of dopamine-induced inhibition and excitation of neurones of the snail Helix aspersa. Arch. int. Pharmacodyn. 209, 324–331 (1974).
Struyker Boudier, H., De Boer, J., Smeets, G., Lien, E., Van Rossum, J. M.: Structure-activity relationships for central and peripheral a-adrenergic activity of imidazoline derivatives. Life Sci. 17, 377–386 (1975 a).
Struyker Boudier, H., Teppema, L., Cools, A.R., Van Rossum, J M.: (3,4-dihydroxyphenylamino)-2-imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibition. J. Pharm. Pharmacol. 27, 882–883 (1975 b).
Woodman, O. L., Medgett, I. C., Lang, W J, Rand, M.J.: Agonistic actions of DPI on a-adrenoceptors and dopamine receptors. Europ. J. Pharmacol. 75, 11–20 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Wien
About this paper
Cite this paper
Cools, A.R., Oosterloo, S.K. (1983). (3,4-Dihydroxyphenylimino)-2-Imidazoline (DPI) and Its Action at Noradrenergic and Dopaminergic Receptors in the Nucleus Accumbens of Rats: Mesolimbic Catecholamine Receptors and Hyperactivity. In: Goldstein, M., Jellinger, K., Riederer, P. (eds) Basic Aspects of Receptor Biochemistry. Journal of Neural Transmission, vol 18. Springer, Vienna. https://doi.org/10.1007/978-3-7091-4408-4_17
Download citation
DOI: https://doi.org/10.1007/978-3-7091-4408-4_17
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-4410-7
Online ISBN: 978-3-7091-4408-4
eBook Packages: Springer Book Archive